Program sesji poświęconej terapii SIMEOX

Międzynarodowa sesja naukowa poświęcona terapii SIMEOX

13 maja 2018 r, godz. 10:15

Znani specjaliści z dziedziny pulmonologii z 6 krajów przedyskutują swoje kliniczne przypadki.

 

Przewodniczący sesji:

  • Pr Martine RAYNAUD-GAUBERT - North University Hospital of Marseille, France
  • Pr Dorota SANDS - Institute of Mother and Child, Poland

Program:

  • Czech Republic Pr Vítězslav KOLEK: University Hospital Olomouc, Department of Respiratory Diseases and Tuberculosis, President of the Czech Respiratory Society, Olomouc
    SIMEOX therapy in obstructive bronchopulmonary patients (Bronchiectasis)
  • France: Dr Thierry PEREZ: University Hospital Lille,  Pneumology Clinic, Cystic Fibrosis Resource and Competence Center.
    SIMEOX therapy in patients with Cystic Fibrosis (CF)
  • Poland : Pr Pawel SLIWINSKI, Institute of Tuberculosis and Lung Diseases, Vice-President of the Polish Respiratory Society, Warsaw
    SIMEOX therapy in patients with pulmonary fibrosis and traction bronchiectasis 
  • Romania : Pr Florin Dumitru MIHALTAN Institut National de Pneumologie Marius Nasta,  past President of the Romanian Respiratory Society, Bucharest
    SIMEOX therapy in COPD patients
  •  Russia : Pr Alexander AVERYANOV, Russian Research Institute of Pulmonology, Moscow 
    Dr Elena AMELINA,  Mucoviscidosis Laboratory, Russian Research Institute of Pulmonology, Moscow
    SIMEOX therapy in patients with Cystic Fibrosis (CF)
  • Slovakia : Associate Pr Ivan SOLOVIC, National Institute of Tuberculosis, Pulmonary Diseases and Thoracic Surgery, Scientific Secretary of the Slovak Respiratory Society, Vyšné Hágy
    SIMEOX therapy in COPD-Asthma patients